Hot Pursuit     29-May-24
Ipca Labs slides as Q4 PAT drops 22% YoY to Rs 60 cr
Ipca Laboratories slipped 2.55% to Rs 1,285.75 after the company’s consolidated net profit 22.12% declined 59.59 crore in Q4 FY24 as against Rs 76.52 crore reported in Q4 FY23.

However, revenue from operations jumped 34.49% year on year to Rs 2,033.01 crore in the quarter ended 31 March 2024.

Profit before tax tumbled 40.82% to Rs 76.60 crore in the March quarter from Rs 129.44 crore posted in Q4 FY23.

EBITDA before forex gain, other income and exceptional items stood at Rs 304.59 crore, registering a growth of 78% YoY.

During the quarter, total formulations were at Rs 1163.48 crore, up 12% YoY. Domestic stood at Rs 689.83 crore (up 13% YoY) and Exports came in at Rs 473.65 crore (up 9.48% YoY) in Q4 FY24.

On a full year basis, the company’s consolidated net profit rose 16.13% to Rs 547.35 crore on 23.39% increase in revenue to Rs 7,705.04 crore in FY24 over FY23.

Meanwhile, the firm’s board has recommended a final dividend of Rs 2 per equity share for the financial year ended 2023-24, subject to the approval of the shareholders.

Ipca Laboratories is an Indian multinational pharmaceutical company. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally.

Previous News
  Ipca Laboratories Ltd soars 0.32%, up for fifth straight session
 ( Hot Pursuit - 27-Mar-24   13:00 )
  Ipca Laboratories Ltd spurts 0.4%, up for five straight sessions
 ( Hot Pursuit - 03-Oct-23   13:00 )
  Ipca Laboratories fixes record date for sub-division of shares
 ( Market Beat - Reports 24-Dec-21   13:06 )
  Board of Ipca Laboratories appoints director
 ( Corporate News - 29-May-24   14:18 )
  Ipca Labs trades near 52-week low after US FDA issue form 483 with 3 observations to Piparia unit
 ( Hot Pursuit - 27-Apr-23   11:21 )
  Ipca Labs inks pact with Omexa Formulary
 ( Hot Pursuit - 27-Mar-24   15:10 )
  Ipca Laboratories Ltd rises for third consecutive session
 ( Hot Pursuit - 25-Jan-24   13:06 )
  Board of Ipca Laboratories recommends interim dividend
 ( Corporate News - 09-Nov-20   13:04 )
  Ipca Laboratories to discuss results
 ( Corporate News - 22-Jul-23   12:29 )
  Ipca Laboratories AGM scheduled
 ( Corporate News - 06-Jul-23   15:26 )
  Ipca Laboratories standalone net profit rises 24.12% in the September 2018 quarter
 ( Results - Announcements 15-Nov-18   16:43 )
Other Stories
  Inox Green Energy board OKs fund raising proposal
  22-Jun-24   17:00
  Cipla Goa facility gets 6 USFDA observations
  22-Jun-24   16:22
  EIH CFO Kallol Kundu resigns
  22-Jun-24   14:20
  Sky Gold acquires entire stake in Starmangalsutra & Sparkling Chains
  22-Jun-24   13:31
  TVS Motor inks pact with CSC Grameen eStores for its CV range
  22-Jun-24   12:27
  Prestige Estates to raise Rs 5000 crore via QIP
  22-Jun-24   11:59
  JSW Energy arm bags LoA from SECI
  22-Jun-24   10:56
  RVNL emerges as L-1 bidder for Rs 191-cr railway project
  22-Jun-24   09:54
  Bajaj Consumer hits 52-week high as board OKs Rs 166-cr share buyback
  21-Jun-24   15:28
  GRM Overseas rallies as board OKs Rs 136-cr preferential issue
  21-Jun-24   15:19
Back Top